Novartis Stock Outperformed the Market Today
Novartis (NYSE: NVS) experienced a nearly 3% rise in share price following the FDA's approval of its medication, Itvisma, for ...
Tag: Novartis
Novartis to spend $23B to expand in the US
Novartis announced plans to invest $23 billion in building and expanding 10 facilities in the US to combat potential drug ...
Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
Swiss pharmaceutical company Novartis reported better-than-expected sales in Q4, with net sales rising 16% to $13.2 billion, exceeding analyst estimates. ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis CEO Vas Narasimhan stated the company will not join the weight loss drug market, focusing instead on unique areas ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.